EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody

Muhammad Waqas Nasir iD, Qiyun Liang, Jun He, Umer Rashid, Jiabing Wu iD, Yong Gao iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.04127-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Muhammad Waqas Nasir und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Viral, Spike Glycoprotein, Coronavirus, Antibodies, Neutralizing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 antigenic evolution continues to erode the activity of first-generation monoclonal antibodies, underscoring the value of antibodies that recognize conserved features within the spike receptor-binding domain (RBD). As a model for breadth-oriented engineering, we assessed the RBD-directed antibody XG83, which has a CDRH3-dominated paratope. Utilizing the XG83-Wuhan RBD crystal structure as a reference, we integrated MOE alanine scanning and residue scanning with CDRH3 (A116-Y132) to identify chemically reasonable replacements and test interaction to an Omicron BA.1 RBD. The parental CDRH3-centric pose in comparative docking had a better score (−280.18) than the mutant MuXG83 (−254.2), along with 100-ns molecular dynamics showed that MuXG83 was less stable (with higher RMSD/RMSF with less favorable interaction energy). The ELISA results against Omicron BA.1 RBD demonstrated that XG83 had 40% stronger binding than MuXG83; convergence happened only at the highest concentration, concordant with SPR studies and the fact that mutation increased dissociation. According to this binding gap, BA.1 pseudovirus neutralization demonstrated that XG83 was much more powerful than MuXG83, showing that the E118L/F130H CDR-H3 alterations decreased functional activity against Omicron BA.1. These results imply that allosteric influences on interface stability and conformational dynamics by non-epitope CDR-H3 residues can affect antibody performance. Functional testing was confined to Omicron BA.1; therefore, larger variant-panel studies are needed to ascertain if such mutations affect antibody breadth. Our findings highlight a structure-guided approach for optimizing paratopes and indicate that non-epitope (potentially allosteric) changes to CDRH3 are also important while investigating potential development and neutralization before advancement. IMPORTANCE This study shows how modest allosteric characteristics in CDR-H3 control the delicate balance between neutralizing potency and breadth, making a timely and significant addition to SARS-CoV-2 antibody engineering. Using crystallography, alanine scanning, residue scanning, docking, molecular dynamics, and experimental ELISA and neutralization assays, this study offers a structure-guided framework for rational paratope optimization. The discovery of CDR-H3 residues that regulate long-range stability rather than just direct epitope contacts reveals an unappreciated aspect of antibody design and explains why some alterations improve anticipated interactions but degrade functional performance. Importantly, the comparison of wild-type XG83 and modified MuXG83 shows how allosteric tuning affects antibody-antigen compatibility in developing variations like Omicron. These findings illuminate conserved RBD recognition and offer strategies for building next-generation therapeutic antibodies that are more resistant to viral evolution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antibodies, ViralSpike Glycoprotein, CoronavirusAntibodies, NeutralizingComplementarity Determining RegionsMutationHumansAntibodies, MonoclonalProtein BindingMolecular Dynamics SimulationMolecular Docking SimulationCOVID-19Binding SitesAllosteric Regulation

Stichwörter der Autor:innen

CDR-H3Omicron variantSARS-CoV-2alanine scanningantibody engineeringmolecular dynamicsmonoclonal antibody XG83spike receptor-binding domain (RBD)

Substanzen

Antibodies, ViralSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, Monoclonalspike protein, SARS-CoV-2Complementarity Determining Regions

Autor:innen und Institutionen

  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.
  • Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
  • Hefei Infectious Disease Hospital, Hefei, China.
  • Department of Chemistry, COMSATS University, Islamabad, Abbottabad, Pakistan.

ORCID-Profile: Muhammad Waqas Nasir, Jiabing Wu, Yong Gao

Zitieren

APA

Nasir, M. W., Liang, Q., He, J., Rashid, U., Wu, J., & Gao, Y. (2026). Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04127-25

Vancouver

Nasir MW, Liang Q, He J, Rashid U, Wu J, Gao Y. Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody. Microbiology Spectrum. 2026. doi:10.1128/spectrum.04127-25

BibTeX
@article{Nasir2026,
  author = {Nasir, Muhammad Waqas and Liang, Qiyun and He, Jun and Rashid, Umer and Wu, Jiabing and Gao, Yong},
  title = {Allosteric effects of CDR-H3 mutations modulate binding and neutralization of a conserved SARS-CoV-2 RBD-targeting antibody},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.04127-25}
}
Kostenlos starten →